{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:01:35Z","timestamp":1783512095907,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03825-8","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:07:46Z","timestamp":1740528466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Therapeutic Efficacy of MS473, a Fully Human Single-Chain Variable Fragment Targeting Staphylococcus aureus Toxic Shock Syndrome Toxin-1, in a D-Galactosamine-Sensitized Mouse Model of Lethal Shock"],"prefix":"10.1186","volume":"25","author":[{"given":"Fatemeh","family":"Rahimi-Jamnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Soezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"1","key":"3825_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s44149-021-00007-7","volume":"1","author":"D-L Hu","year":"2021","unstructured":"Hu D-L, Li S, Fang R, Ono HK. Update on molecular diversity and multipathogenicity of staphylococcal superantigen toxins. Animal Diseases. 2021;1(1):7.","journal-title":"Animal Diseases"},{"issue":"10","key":"3825_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","volume":"22","author":"WR Miller","year":"2024","unstructured":"Miller WR, Arias CA. ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics. Nat Rev Microbiol. 2024;22(10):598\u2013616.","journal-title":"Nat Rev Microbiol"},{"key":"3825_CR3","doi-asserted-by":"crossref","unstructured":"Soltanmohammadi B, Piri-Gavgani S, Basardeh E, Ghanei M, Azizi M, Khaksar Z, et al. Bactericidal fully human single-chain fragment variable antibodies protect mice against methicillin-resistant Staphylococcus aureus bacteraemia. Clin Transl Immunol. 2021;10(7):e1302.","DOI":"10.1002\/cti2.1302"},{"issue":"10","key":"3825_CR4","doi-asserted-by":"publisher","first-page":"e13253","DOI":"10.1371\/journal.pone.0013253","volume":"5","author":"EA Larkin","year":"2010","unstructured":"Larkin EA, Stiles BG, Ulrich RG. Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B. PLoS ONE. 2010;5(10):e13253.","journal-title":"PLoS ONE"},{"issue":"6","key":"3825_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1586\/ecp.10.121","volume":"3","author":"YC Lin","year":"2010","unstructured":"Lin YC, Peterson ML. New insights into the prevention of staphylococcal infections and toxic shock syndrome. Expert Rev Clin Pharmacol. 2010;3(6):753\u201367.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"3825_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12896-022-00760-8","volume":"22","author":"M Soezi","year":"2022","unstructured":"Soezi M, Piri-Gavgani S, Ghanei M, Omrani MD, Soltanmohammadi B, Bagheri KP, et al. Identification of a novel fully human anti-toxic shock syndrome toxin (TSST)-1 single-chain variable fragment antibody averting TSST-1-induced mitogenesis and cytokine secretion. BMC Biotechnol. 2022;22(1):31.","journal-title":"BMC Biotechnol"},{"issue":"1","key":"3825_CR7","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1038\/s41598-018-21141-2","volume":"8","author":"C Kong","year":"2018","unstructured":"Kong C, Chee CF, Richter K, Thomas N, Abd Rahman N, Nathan S. Suppression of Staphylococcus aureus biofilm formation and virulence by a benzimidazole derivative, UM-C162. Sci Rep. 2018;8(1):2758.","journal-title":"Sci Rep"},{"issue":"11","key":"3825_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/toxins14110800","volume":"14","author":"S Noli Truant","year":"2022","unstructured":"Noli Truant S, Redolfi DM, Sarratea MB, Malchiodi EL, Fern\u00e1ndez MM. Superantigens, a paradox of the immune response. Toxins (Basel). 2022;14(11):800.","journal-title":"Toxins (Basel)"},{"key":"3825_CR9","unstructured":"Chu VH. Staphylococcal toxic shock syndrome. In: UpToDate, Connor RF (Ed), Wolters Kluwer. Accessed Nov 2024."},{"issue":"2","key":"3825_CR10","first-page":"246","volume":"14","author":"HC Chen","year":"2024","unstructured":"Chen HC, Pan YL, Chen Y, Yang TH, Hsu ET, Huang YT, Chiang MH. Monoclonal Antibodies as a Therapeutic Strategy against Multidrug-Resistant Bacterial Infections in a Post-COVID-19 Era. Life (Basel). 2024;14(2):246.","journal-title":"Life (Basel)"},{"key":"3825_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.omto.2019.02.004","volume":"14","author":"R Ahamadi-Fesharaki","year":"2019","unstructured":"Ahamadi-Fesharaki R, Fateh A, Vaziri F, Solgi G, Siadat SD, Mahboudi F, Rahimi-Jamnani F. Single-chain variable fragment-based bispecific antibodies: Hitting two targets with one sophisticated arrow. Mol Ther Oncolytics. 2019;14:38\u201356.","journal-title":"Mol Ther Oncolytics"},{"issue":"2","key":"3825_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/toxins9020050","volume":"9","author":"T Rukkawattanakul","year":"2017","unstructured":"Rukkawattanakul T, Sookrung N, Seesuay W, Onlamoon N, Diraphat P, Chaicumpa W, Indrawattana N. Human scFvs that counteract bioactivities of Staphylococcus aureus TSST-1. Toxins (Basel). 2017;9(2):50.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"3825_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/antib7010005","volume":"7","author":"SX Wang-Lin","year":"2018","unstructured":"Wang-Lin SX, Balthasar JP. Pharmacokinetic and pharmacodynamic considerations for the use of monoclonal antibodies in the treatment of bacterial infections. Antibodies (Basel). 2018;7(1):5.","journal-title":"Antibodies (Basel)"},{"issue":"1","key":"3825_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1128\/iai.56.1.135-141.1988","volume":"56","author":"PF Bonventre","year":"1988","unstructured":"Bonventre PF, Thompson MR, Adinolfi LE, Gillis ZA, Parsonnet J. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infec Immun. 1988;56(1):135\u201341.","journal-title":"Infec Immun"},{"issue":"2","key":"3825_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1139\/w99-121","volume":"46","author":"WW Kum","year":"2000","unstructured":"Kum WW, Laupland KB, Chow AW. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality. Can J Microbiol. 2000;46(2):171\u20139.","journal-title":"Can J Microbiol"},{"issue":"2","key":"3825_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1046\/j.1365-2249.1999.01061.x","volume":"118","author":"M Verdrengh","year":"1999","unstructured":"Verdrengh M, Kum W, Chow A, Tarkowski A. The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis. Clin Exp Immunol. 1999;118(2):268\u201370.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"3825_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12866-023-03080-9","volume":"24","author":"E Basardeh","year":"2024","unstructured":"Basardeh E, Piri-Gavgani S, Moradi HR, Azizi M, Mirzabeigi P, Nazari F, et al. Anti-Acinetobacter baumannii single-chain variable fragments provide therapeutic efficacy in an immunocompromised mouse pneumonia model. BMC Microbiol. 2024;24(1):55.","journal-title":"BMC Microbiol"},{"key":"3825_CR18","doi-asserted-by":"publisher","first-page":"697876","DOI":"10.3389\/fcimb.2021.697876","volume":"11","author":"KDR Roth","year":"2021","unstructured":"Roth KDR, Wenzel EV, Ruschig M, Steinke S, Langreder N, Heine PA, et al. Developing recombinant antibodies by phage display against infectious diseases and toxins for diagnostics and therapy. Fron Cell Infect Microbiol. 2021;11:697876.","journal-title":"Fron Cell Infect Microbiol"},{"issue":"10","key":"3825_CR19","first-page":"1207","volume":"25","author":"S Piri-Gavgani","year":"2022","unstructured":"Piri-Gavgani S, Ghanei M, Fateh A, Siadat SD, Nematollahi L, Rahimi-Jamnani F. Identification of two neutralizing human single-chain variable fragment antibodies targeting Staphylococcus aureus alpha-hemolysin. Iran J of Basic Med Sci. 2022;25(10):1207\u201314.","journal-title":"Iran J of Basic Med Sci"},{"key":"3825_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","volume":"55","author":"JK McCormick","year":"2001","unstructured":"McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 2001;55:77\u2013104.","journal-title":"Annu Rev Microbiol"},{"key":"3825_CR21","doi-asserted-by":"publisher","first-page":"102404","DOI":"10.1016\/j.eclinm.2023.102404","volume":"67","author":"C Schoergenhofer","year":"2024","unstructured":"Schoergenhofer C, Gelbenegger G, Hasanacevic D, Schoner L, Steiner MM, Firbas C, et al. A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results. EClinicalMedicine. 2024;67:102404.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"3825_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/toxins11030178","volume":"11","author":"T Krakauer","year":"2019","unstructured":"Krakauer T. Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock. Toxins (Basel). 2019;11(3):178.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"3825_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","volume":"37","author":"A Al Shoyaib","year":"2019","unstructured":"Al Shoyaib A, Archie SR, Karamyan VT. Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies? Pharm Res. 2019;37(1):12.","journal-title":"Pharm Res"},{"issue":"3","key":"3825_CR24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1128\/iai.51.3.891-895.1986","volume":"51","author":"MA Freudenberg","year":"1986","unstructured":"Freudenberg MA, Keppler D, Galanos C. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun. 1986;51(3):891\u20135.","journal-title":"Infect Immun"},{"issue":"4","key":"3825_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/74672","volume":"6","author":"G Arad","year":"2000","unstructured":"Arad G, Levy R, Hillman D, Kaempfer R. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat Med. 2000;6(4):414\u201321.","journal-title":"Nat Med"},{"issue":"1","key":"3825_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.175.1.91","volume":"175","author":"T Miethke","year":"1992","unstructured":"Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med. 1992;175(1):91\u20138.","journal-title":"J Exp Med"},{"issue":"1","key":"3825_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41541-023-00783-y","volume":"9","author":"PV Scaria","year":"2024","unstructured":"Scaria PV, Roth N, Schwendt K, Muratova OV, Alani N, Lambert LE, et al. mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response. NPJ Vaccines. 2024;9(1):9.","journal-title":"NPJ Vaccines"},{"issue":"2","key":"3825_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11357-011-9232-6","volume":"34","author":"A Gesing","year":"2012","unstructured":"Gesing A, Masternak MM, Wang F, Karbownik-Lewinska M, Bartke A. Deletion of growth hormone receptor gene but not visceral fat removal decreases expression of apoptosis-related genes in the kidney\u2014potential mechanism of lifespan extension. Age. 2012;34(2):295\u2013304.","journal-title":"Age"},{"issue":"1","key":"3825_CR29","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/s41598-019-39890-z","volume":"9","author":"A Venkatasubramaniam","year":"2019","unstructured":"Venkatasubramaniam A, Adhikari RP, Kort T, Liao GC, Conley S, Abaandou L, et al. TBA225, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens. Sci Rep. 2019;9(1):3279.","journal-title":"Sci Rep"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03825-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03825-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03825-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:07:48Z","timestamp":1740528468000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03825-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3825"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03825-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4950434\/v1","asserted-by":"object"}]},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were conducted in accordance with ARRIVE guidelines (\n                      \n                      ) and approved by the Animal Care and Use Committees of the Pasteur Institute of Iran (IR.PII.REC.1398.028). All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}